ABVX vs ARRY vs JPM vs BAC vs SHLS

For growth investors, Array Technologies, Inc.

(ARRY) is the stronger pick with 40. 2% revenue growth year-over-year, versus -0. 5% for Bank of America Corporation (BAC). Bank of America Corporation (BAC) offers the better valuation at 14. 4x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Abivax S. A. (ABVX) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.

4x versus Shoals Technologies Group, Inc. at 49. 5x. On forward P/E, Array Technologies, Inc. is actually cheaper at 10. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Bank of America Corporation wins at 0. 82x versus JPMorgan Chase & Co. 's 1. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, Abivax S.

A. (ABVX) delivered a total return of +1115%, compared to -67. 7% for Shoals Technologies Group, Inc. (SHLS). Over 10 years, the gap is even starker: ABVX returned +1063% versus ARRY's -78. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Bank of America Corporation (BAC) is the lower-risk stock at 0.

86β versus Shoals Technologies Group, Inc. 's 2. 57β — meaning SHLS is approximately 197% more volatile than BAC relative to the S&P 500. On balance sheet safety, Abivax S. A. (ABVX) carries a lower debt/equity ratio of 7% versus 3% for Array Technologies, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Array Technologies, Inc.

(ARRY) is pulling ahead at 40. 2% versus -0. 5% for Bank of America Corporation (BAC). On earnings-per-share growth, the picture is similar: Array Technologies, Inc. grew EPS 62. 6% year-over-year, compared to -66. 1% for Abivax S. A.. Over a 3-year CAGR, SHLS leads at 13. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -4. 1% for Array Technologies, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 0. 0% for ABVX. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Bank of America Corporation (BAC) is the more undervalued stock at a PEG of 0. 82x versus JPMorgan Chase & Co. 's 1. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Array Technologies, Inc. (ARRY) trades at 10. 2x forward P/E versus 25. 3x for Shoals Technologies Group, Inc. — 15. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARRY: 31. 5% to $9. 80.

In this comparison, BAC (2.

3% yield), JPM (1. 9% yield) pay a dividend. ABVX, ARRY, SHLS do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Bank of America Corporation (BAC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

86), 2. 3% yield, +368. 2% 10Y return). Array Technologies, Inc. (ARRY) carries a higher beta of 2. 47 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BAC: +368. 2%, ARRY: -78. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ABVX (Healthcare) and ARRY (Energy) and JPM (Financial Services) and BAC (Financial Services) and SHLS (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ABVX is a small-cap quality compounder stock; ARRY is a small-cap high-growth stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; SHLS is a small-cap high-growth stock. JPM, BAC pay a dividend while ABVX, ARRY, SHLS do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.